Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and HealthcareBusiness Overview: IBL has multiple business units managed by an independent team of field experts. It operates in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure
Indrayani Biotech Ltd has approved the Letter of Offer for its rights issue of up to 3,25,25,897 partly paid-up equity shares with a face value of ₹10 each. The shares are priced at ₹15 each, aggregating up to ₹48.79 Cr, and will be offered in the ratio of 5 rights...
Indrayani Biotech Ltd has appointed Mr. C.S. Shanmuga Sundar as the new Company Secretary and Compliance Officer, filling the vacancy left by the previous departure. This leadership update strengthens the company's internal governance framework and ensures seamless handling of statutory obligations and stakeholder communications. Retail investors should view this administrative...
Indrayani Biotech Ltd has announced that Mr. K. Ravichandran has resigned from his position as the Secretarial Auditor of the company due to personal reasons. This departure creates a vacancy in the secretarial audit function, which is crucial for ensuring corporate governance and legal compliance. To maintain operational continuity and...
Indrayani Biotech has secured a two-month extension from the Registrar of Companies to hold its upcoming Annual General Meeting. This extra time is necessary because the company is currently planning a capital restructuring, which includes a Rights Issue and requires multiple approvals. For retail investors, this means management is focused...
IBL Indrayani Biotech has announced the publication of its audited financial results for the quarter and year ended March 31, 2026. The company's Board of Directors approved these results at a meeting. This update provides shareholders with a transparent overview of IBL's recent financial performance. Investors can access the detailed...
